Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ultragenyx Pharmaceutical Inc. buy Guggenheim

Ultragenyx Pharmaceutical Inc.
Start price
€32.00
20.06.25 / 50%
Target price
€55.59
20.06.26
Performance (%)
-38.44%
Price
€19.70
10.04.26
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Ultragenyx Pharmaceutical Inc. is performing very badly with a performance of -38.44%. This prediction currently runs until 20.06.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ultragenyx Pharmaceutical Inc. 2.073% 2.073%
iShares Core DAX® 2,55 % 0,56 %
iShares Nasdaq 100 2,74 % -0,60 %
iShares Nikkei 225® 6,58 % 4,34 %
iShares S&P 500 1,93 % -0,51 %

Comments by Guggenheim for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -38.44%
Target price 55.590
Change
Ends at 20.06.26

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $64.00 price target on the stock.
Ratings data for RARE provided by MarketBeat

Guggenheim 
0
Report Share
20.06.25

Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€20.00
05.01.26
€44.47
05.01.27
-0.65%
10.04.26

Guggenheim 
05.01.26 50%